Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects
Clinical trial NCT00619346 · TERMINATED
Trial details
- NCT number
- NCT00619346
- Sponsor
- Immtech Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.